Asia · Regional markets · Pulse (Maeil Business)

U.S. cancer genomics firm Inocras clears key hurdle for Kosdaq listing

Published by Pulse (Maeil Business) · South Korea 11 h ago

Inocras Inc., a U.S.-based precision cancer genomics diagnostics company, has passed the technology assessment required for a special-track listing on South Korea’s secondary…

Read the full article on Pulse (Maeil Business) Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (pulse.mk.co.kr)

Also worth reading

Mint

Meta share price: Stock slumps 7.5% despite upbeat Q3 results; why is Facebook parent falling?

CNBC-TV18

US 10-year yield falls below 5% as investors flock to havens

Business Standard

Jio Platforms IPO subscribed 5.57x on day 2; QIBs led with 13.29x bids

The Straits Times Business

TSH Resources reports 274 hot spots within estate boundaries after SGX queries over haze

The Business Times

Firms here should ‘act now’ to fix critical PHP vulnerabilities: Singapore’s cybersecurity chief

Tech in Asia